Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Protein & Cell ; (12): 762-775, 2023.
Artigo em Inglês | WPRIM | ID: wpr-1010779

RESUMO

The gut microbiota has been found to interact with the brain through the microbiota-gut-brain axis, regulating various physiological processes. In recent years, the impacts of the gut microbiota on neurodevelopment through this axis have been increasingly appreciated. The gut microbiota is commonly considered to regulate neurodevelopment through three pathways, the immune pathway, the neuronal pathway, and the endocrine/systemic pathway, with overlaps and crosstalks in between. Accumulating studies have identified the role of the microbiota-gut-brain axis in neurodevelopmental disorders including autism spectrum disorder, attention deficit hyperactivity disorder, and Rett Syndrome. Numerous researchers have examined the physiological and pathophysiological mechanisms influenced by the gut microbiota in neurodevelopmental disorders (NDDs). This review aims to provide a comprehensive overview of advancements in research pertaining to the microbiota-gut-brain axis in NDDs. Furthermore, we analyzed both the current state of research progress and discuss future perspectives in this field.


Assuntos
Humanos , Eixo Encéfalo-Intestino , Transtorno do Espectro Autista/metabolismo , Encéfalo/metabolismo , Microbioma Gastrointestinal , Transtornos do Neurodesenvolvimento/metabolismo
2.
Neuroscience Bulletin ; (6): 1623-1637, 2023.
Artigo em Inglês | WPRIM | ID: wpr-1010623

RESUMO

Autism spectrum disorder (ASD) is one of the common neurodevelopmental disorders in children. Its etiology and pathogenesis are poorly understood. Previous studies have suggested potential changes in the complement and coagulation pathways in individuals with ASD. In this study, using multiple reactions monitoring proteomic technology, 16 of the 33 proteins involved in this pathway were identified as differentially-expressed proteins in plasma between children with ASD and controls. Among them, CFHR3, C4BPB, C4BPA, CFH, C9, SERPIND1, C8A, F9, and F11 were found to be altered in the plasma of children with ASD for the first time. SERPIND1 expression was positively correlated with the CARS score. Using the machine learning method, we obtained a panel composed of 12 differentially-expressed proteins with diagnostic potential for ASD. We also reviewed the proteins changed in this pathway in the brain and blood of patients with ASD. The complement and coagulation pathways may be activated in the peripheral blood of children with ASD and play a key role in the pathogenesis of ASD.


Assuntos
Criança , Humanos , Transtorno do Espectro Autista/metabolismo , Proteômica , Encéfalo/metabolismo
3.
Neuroscience Bulletin ; (6): 1469-1480, 2023.
Artigo em Inglês | WPRIM | ID: wpr-1010613

RESUMO

Autism spectrum disorder (ASD) is a highly heritable neurodevelopmental disorder characterized by deficits in social interactions and repetitive behaviors. Although hundreds of ASD risk genes, implicated in synaptic formation and transcriptional regulation, have been identified through human genetic studies, the East Asian ASD cohorts are still under-represented in genome-wide genetic studies. Here, we applied whole-exome sequencing to 369 ASD trios including probands and unaffected parents of Chinese origin. Using a joint-calling analytical pipeline based on GATK toolkits, we identified numerous de novo mutations including 55 high-impact variants and 165 moderate-impact variants, as well as de novo copy number variations containing known ASD-related genes. Importantly, combined with single-cell sequencing data from the developing human brain, we found that the expression of genes with de novo mutations was specifically enriched in the pre-, post-central gyrus (PRC, PC) and banks of the superior temporal (BST) regions in the human brain. By further analyzing the brain imaging data with ASD and healthy controls, we found that the gray volume of the right BST in ASD patients was significantly decreased compared to healthy controls, suggesting the potential structural deficits associated with ASD. Finally, we found a decrease in the seed-based functional connectivity between BST/PC/PRC and sensory areas, the insula, as well as the frontal lobes in ASD patients. This work indicated that combinatorial analysis with genome-wide screening, single-cell sequencing, and brain imaging data reveal the brain regions contributing to the etiology of ASD.


Assuntos
Humanos , Transtorno do Espectro Autista/metabolismo , Transtorno Autístico , Sequenciamento do Exoma , Variações do Número de Cópias de DNA , População do Leste Asiático , Encéfalo/metabolismo , Mutação/genética , Predisposição Genética para Doença/genética
4.
Neuroscience Bulletin ; (6): 1333-1347, 2023.
Artigo em Inglês | WPRIM | ID: wpr-1010605

RESUMO

Brain size abnormality is correlated with an increased frequency of autism spectrum disorder (ASD) in offspring. Genetic analysis indicates that heterozygous mutations of the WD repeat domain 62 (WDR62) are associated with ASD. However, biological evidence is still lacking. Our study showed that Wdr62 knockout (KO) led to reduced brain size with impaired learning and memory, as well as ASD-like behaviors in mice. Interestingly, Wdr62 Nex-cKO mice (depletion of WDR62 in differentiated neurons) had a largely normal brain size but with aberrant social interactions and repetitive behaviors. WDR62 regulated dendritic spinogenesis and excitatory synaptic transmission in cortical pyramidal neurons. Finally, we revealed that retinoic acid gavages significantly alleviated ASD-like behaviors in mice with WDR62 haploinsufficiency, probably by complementing the expression of ASD and synapse-related genes. Our findings provide a new perspective on the relationship between the microcephaly gene WDR62 and ASD etiology that will benefit clinical diagnosis and intervention of ASD.


Assuntos
Camundongos , Animais , Microcefalia/genética , Transtorno Autístico/metabolismo , Transtorno do Espectro Autista/metabolismo , Proteínas do Tecido Nervoso/metabolismo , Encéfalo/metabolismo , Camundongos Knockout , Proteínas de Ciclo Celular/metabolismo
5.
Neuroscience Bulletin ; (6): 249-262, 2022.
Artigo em Inglês | WPRIM | ID: wpr-929098

RESUMO

The radial migration of cortical pyramidal neurons (PNs) during corticogenesis is necessary for establishing a multilayered cerebral cortex. Neuronal migration defects are considered a critical etiology of neurodevelopmental disorders, including autism spectrum disorders (ASDs), schizophrenia, epilepsy, and intellectual disability (ID). TRIO is a high-risk candidate gene for ASDs and ID. However, its role in embryonic radial migration and the etiology of ASDs and ID are not fully understood. In this study, we found that the in vivo conditional knockout or in utero knockout of Trio in excitatory precursors in the neocortex caused aberrant polarity and halted the migration of late-born PNs. Further investigation of the underlying mechanism revealed that the interaction of the Trio N-terminal SH3 domain with Myosin X mediated the adherence of migrating neurons to radial glial fibers through regulating the membrane location of neuronal cadherin (N-cadherin). Also, independent or synergistic overexpression of RAC1 and RHOA showed different phenotypic recoveries of the abnormal neuronal migration by affecting the morphological transition and/or the glial fiber-dependent locomotion. Taken together, our findings clarify a novel mechanism of Trio in regulating N-cadherin cell surface expression via the interaction of Myosin X with its N-terminal SH3 domain. These results suggest the vital roles of the guanine nucleotide exchange factor 1 (GEF1) and GEF2 domains in regulating radial migration by activating their Rho GTPase effectors in both distinct and cooperative manners, which might be associated with the abnormal phenotypes in neurodevelopmental disorders.


Assuntos
Humanos , Transtorno do Espectro Autista/metabolismo , Movimento Celular/genética , Interneurônios/metabolismo , Transtornos do Neurodesenvolvimento/genética , Neurônios/metabolismo , Fatores de Troca de Nucleotídeo Guanina Rho/genética
6.
Arch. argent. pediatr ; 118(3): e271-e277, jun. 2020.
Artigo em Inglês, Espanhol | LILACS, BINACIS | ID: biblio-1116919

RESUMO

Los problemas médicos gastrointestinales, nutricionales, metabólicos, endocrinológicos y de microbiota en los pacientes pediátricos con diagnóstico de trastorno del espectro autista (TEA) son parte de los problemas médicos concomitantes al diagnóstico. La prevalencia alcanza a más del 91 % en el caso de los problemas gastrointestinales, hasta el 89 % para los nutricionales y metabólicos, más del 50 % de disfunción tiroidea y hasta el 100 % para los relacionados con la microbiota.Es urgente actualizar la práctica médica para incluir la evaluación, testeo, diagnóstico y tratamiento de estos problemas médicos concomitantes al diagnóstico de TEA en la población pediátrica, adolescente y adulta. El tratamiento riguroso de dichos problemas genera cambios positivos en la calidad de vida y en la sintomatología bajo la cual el TEA se diagnostica en muchos casos. Debe basarse en evidencia científica de alta calidad, con control y cuidado médico adecuado


Gastrointestinal, nutritional, metabolic, endocrine, and microbiota medical problems in pediatric patients diagnosed with autism spectrum disorder (ASD) are some of the coexisting medical conditions in ASD diagnosis. Their prevalence reaches more than 91 % for gastrointestinal problems, up to 89 % for nutritional and metabolic disorders, more than 50 % for thyroid dysfunction, and up to 100 % for microbiota-related conditions.There is an urgency for medical practice to be updated and to include the assessment, testing, diagnosis, and treatment of these coexisting medical conditions in ASD diagnosis in the pediatric, adolescent, and adult population. A strict management of such conditions results in positive changes in the quality of life and symptoms based on which ASD is diagnosed many times. It should be based on high-quality scientific evidence with an adequate medical care and control


Assuntos
Humanos , Pré-Escolar , Criança , Adolescente , Doenças do Sistema Endócrino/metabolismo , Microbiota , Transtorno do Espectro Autista/microbiologia , Gastroenteropatias/metabolismo , Sintomas Concomitantes , Estado Nutricional , Transtorno do Espectro Autista/complicações , Transtorno do Espectro Autista/dietoterapia , Transtorno do Espectro Autista/metabolismo , Gastroenteropatias/complicações , Gastroenteropatias/dietoterapia
7.
Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; 38(3): 243-246, July-Sept. 2016.
Artigo em Inglês | LILACS | ID: lil-792749

RESUMO

Autism spectrum disorders (ASDs) are characterized by deficits in the individual’s ability to socialize, communicate, and use the imagination, in addition to stereotyped behaviors. These disorders have a heterogenous phenotype, both in relation to symptoms and regarding severity. Organic problems related to the gastrointestinal tract are often associated with ASD, including dysbiosis, inflammatory bowel disease, exocrine pancreatic insufficiency, celiac disease, indigestion, malabsorption, food intolerance, and food allergies, leading to vitamin deficiencies and malnutrition. In an attempt to explain the pathophysiology involved in autism, a theory founded on opioid excess has been the focus of various investigations, since it partially explains the symptomatology of the disorder. Another hypothesis has been put forward whereby the probable triggers of ASDs would be related to the presence of bacteria in the bowel, oxidative stress, and intestinal permeability. The present update reviews these hypotheses.


Assuntos
Humanos , Peptídeos Opioides/efeitos adversos , Peptídeos Opioides/metabolismo , Transtorno do Espectro Autista/etiologia , Transtorno do Espectro Autista/metabolismo , Gastroenteropatias/metabolismo , Compostos de Sulfidrila/metabolismo , Estresse Oxidativo , Peptídeos Opioides/análise , Trato Gastrointestinal/fisiopatologia , Trato Gastrointestinal/metabolismo , Trato Gastrointestinal/microbiologia , Transtorno do Espectro Autista/fisiopatologia , Microbioma Gastrointestinal , Gastroenteropatias/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA